SLC12A8-BCAS1 Fusion FISH Probe
The SLC12A8-BCAS1 Fusion FISH Probe is used to confirm a fusion of the SLC12A8 and BCAS1 genes. The fusion of the SLC12A8 and BCAS1 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC12A8-BCAS1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC12A8-BCAS1-20-AQAQ | 20 (40 μL) | 200 μL |
|
BCAS1 Gene Summary
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene. [provided by RefSeq, Apr 2016]
Gene Name: Breast Carcinoma Amplified Sequence 1
Chromosome: CHR20: 52560078 -52687304
Locus: 20q13.2
SLC12A8 Gene Summary
This gene is thought to be a candidate for psoriasis susceptibility. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Sep 2010]
Gene Name: Solute Carrier Family 12 Member 8
Chromosome: CHR3: 124801479 -124931609
Locus: 3q21.2
Gene Diseases
The SLC12A8 BCAS1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|